Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Dermatology · Folliculitis Decalvans

Understanding Folliculitis Decalvans: What to Expect

At a Glance

Folliculitis decalvans is a chronic inflammatory scalp condition that can permanently destroy hair follicles. Treatment aims to calm inflammation, relieve symptoms, and prevent further scarring; new firm lumps, non-healing sores, or unusual bleeding need prompt review.

Folliculitis decalvans (FD), also known as Quinquaud folliculitis, is a rare and chronic inflammatory condition that affects the hair follicles on the scalp [1][NCT07268534]. It is classified as a primary cicatricial alopecia (scarring alopecia), meaning the inflammation specifically targets and can destroy the hair follicle, replacing it with permanent scar tissue [2][NCT07268534].

While a diagnosis of FD can feel overwhelming, understanding the nature of the condition is the first step toward managing it effectively. The primary goal of medical care is to “put out the fire” of inflammation to stop the progression of scarring and protect the hair you still have [2][3].

Understanding the Rarity and Reach of FD

Folliculitis decalvans is uncommon. Research from specialized hair clinics around the world indicates that it accounts for approximately 2.8% of all hair loss diagnoses in those specialized settings [4]. It can affect individuals of any ethnic background and geographic location [4][5].

Data from these patient groups show certain trends in who is typically diagnosed:

  • Age: Most people are diagnosed in adulthood, with the average age at presentation typically falling between 35 and 40 years [6][7].
  • Sex: There is a slight male predominance, with some studies suggesting men make up about 62% to 63% of cases [6][7].
  • Severity: While it can occur at any age, developing the condition before the age of 25 is sometimes associated with a more severe disease course in these cohorts [6][7].

The Emotional Impact of Scarring Alopecia

Living with a condition that causes visible changes to your appearance can be distressing. Research involving broad groups of patients with various scarring alopecias shows that more than 70% experience a significant impact on their quality of life [8]. Symptoms like trichodynia (scalp pain or tenderness) are closely linked to higher levels of anxiety and emotional burden [8].

It is important to acknowledge that the hair loss in FD is permanent in areas where scarring has already occurred [2]. However, this does not mean the situation is hopeless. Modern treatments are designed to control the inflammation, ease symptoms like pain and itching, and prevent the “scarring front” from moving further [2][9]. Psychological support and specialized camouflage techniques are standard parts of comprehensive care [2].

When to Seek Prompt Care vs. Emergency Care

While folliculitis decalvans is a long-term (chronic) condition characterized by relapses, certain changes require medical evaluation. In very rare cases, long-standing inflammatory scars can develop into a type of skin cancer called squamous cell carcinoma (SCC) [10][11].

Because chronic inflammation is a known risk factor for these rare changes, you should contact your dermatologist promptly if you notice any of the following “red flags” in a scarred area [12][13][11]:

  • A new, firm, or thickening lump (induration).
  • A sore or ulcer that does not heal within a few weeks.
  • Persistent bleeding or crusting that is distinctly different from your usual flares.
  • A focal change unlike the patient’s usual disease that does not respond to your standard treatments as it usually does.

Prompt assessment and a biopsy—where a small sample of tissue is removed for testing—are important to rule out complications and ensure you are receiving the correct treatment for your specific situation [13][12]. (Note: Most changes during a flare are not cancer. SCC is an exceptionally uncommon occurrence in FD).

Emergency Care: Seek immediate emergency medical attention if you experience signs of a serious systemic infection, such as high fever, rapidly spreading redness or swelling beyond the scalp, severe escalating pain, or severe diarrhea (especially if taking antibiotics).

Common questions in this guide

What is folliculitis decalvans and why does it cause scarring?
Folliculitis decalvans is a rare, chronic inflammatory condition that affects hair follicles on the scalp. Inflammation can destroy a follicle and replace it with scar tissue, leading to permanent hair loss in that area.
Is hair loss from folliculitis decalvans permanent?
Hair generally cannot regrow in an area where the follicle has already been replaced by scar tissue. Treatment focuses on calming active inflammation, relieving symptoms, and preventing the scarring process from affecting more follicles.
What symptoms can folliculitis decalvans cause?
Folliculitis decalvans may cause scalp redness, pustules, hair loss, pain or tenderness, itching, and burning. Symptoms can flare and settle over time, so report changes in disease activity to your dermatologist.
How does a scalp biopsy help diagnose folliculitis decalvans?
A scalp biopsy removes a small sample of tissue for examination. It can help confirm folliculitis decalvans and rule out other conditions that may look similar, helping your dermatologist choose appropriate care.
What are the goals of treatment for folliculitis decalvans?
Treatment aims to control inflammation, ease pain and itching, and stop further scarring. Because established scar-related hair loss may not reverse, care may also include psychological support and camouflage techniques, with goals such as stabilization, comfort, or appearance.
Which new scalp changes should be checked promptly?
Contact your dermatologist promptly if you notice a new firm or thickening lump, a sore that does not heal, persistent bleeding or crusting unlike your usual flares, or a focal change that does not respond to usual treatment. Most flare-related changes are not cancer, but an examination and sometimes a biopsy can check for rare complications such as squamous cell carcinoma.
When should I seek emergency care for folliculitis decalvans?
Seek emergency care for a high fever, rapidly spreading redness or swelling beyond the scalp, severe escalating pain, or severe diarrhea, especially while taking antibiotics. These symptoms may signal a serious problem that needs immediate assessment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Has a scalp biopsy been performed to confirm my diagnosis and rule out other conditions?
  2. 2.What is my current level of disease activity, and how will we track it over time?
  3. 3.What are the specific goals for my treatment—am I aiming for hair regrowth or stabilization?
  4. 4.What specific changes should prompt me to call the clinic between scheduled visits?
  5. 5.Are there specific support groups or psychological resources you recommend for patients living with scarring alopecia?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Primary cicatricial alopecia in a single-race Asian population: A 10-year nationwide population-based study in South Korea.

    Yoon J, Choi JW

    The Journal of dermatology 2018; (45(11)):1306-1311 doi:10.1111/1346-8138.14625.

    PMID: 30188582
  2. 2

    Cicatricial alopecia.

    Kanti V, Röwert-Huber J, Vogt A, Blume-Peytavi U

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2018; (16(4)):435-461 doi:10.1111/ddg.13498.

    PMID: 29645394
  3. 3

    A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris.

    Svigos K, Yin L, Fried L, et al.

    American journal of clinical dermatology 2021; (22(5)):681-692 doi:10.1007/s40257-021-00630-7.

    PMID: 34347282
  4. 4

    Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study.

    Vañó-Galván S, Saceda-Corralo D, Blume-Peytavi U, et al.

    Skin appendage disorders 2019; (5(5)):309-315 doi:10.1159/000496708.

    PMID: 31559256
  5. 5

    Epidemiological, Clinical, and Therapeutic Insights into Folliculitis Decalvans in Skin of Color: A Retrospective Descriptive Study of 17 Cases.

    Loubaris Z, Taib HE, Benzekri L, Meziane M

    Skin appendage disorders 2025; (11(6)):482-487 doi:10.1159/000546565.

    PMID: 40584732
  6. 6

    Folliculitis decalvans: a multicentre review of 82 patients.

    Vañó-Galván S, Molina-Ruiz AM, Fernández-Crehuet P, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2015; (29(9)):1750-7 doi:10.1111/jdv.12993.

    PMID: 25682915
  7. 7

    Folliculitis decalvans: Effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up.

    Miguel-Gómez L, Rodrigues-Barata AR, Molina-Ruiz A, et al.

    Journal of the American Academy of Dermatology 2018; (79(5)):878-883 doi:10.1016/j.jaad.2018.05.1240.

    PMID: 29864465
  8. 8

    Health-related quality of life (hrQoL) among patients with primary cicatricial alopecia (PCA): A systematic review.

    Singh R, Wilborn D, Lintzeri DA, Blume-Peytavi U

    Journal of the European Academy of Dermatology and Venereology : JEADV 2023; (37(12)):2462-2473 doi:10.1111/jdv.19381.

    PMID: 37478298
  9. 9

    Management of folliculitis decalvans: The EADV task force on hair diseases position statement.

    Waśkiel-Burnat A, Starace M, Iorizzo M, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2025; (39(8)):1385-1394 doi:10.1111/jdv.20687.

    PMID: 40230058
  10. 10

    Squamous cell carcinoma originating in folliculitis decalvans.

    Luu Y, Kimmis BD, Pulumati A, et al.

    Dermatology online journal 2025; (31(1)) doi:10.5070/D331164986.

    PMID: 40526940
  11. 11

    Metastatic squamous cell carcinoma arising in the setting of folliculitis decalvans.

    Esaa F, Shah PR, Dolohanty LB

    Dermatology online journal 2019; (25(4)).

    PMID: 31046918
  12. 12

    Giant cutaneous squamous cell carcinoma of the scalp arising in the setting of folliculitis decalvans.

    Ding L, DeGiovanni JC, Bogner P, Soofi Y

    BMJ case reports 2022; (15(3)) doi:10.1136/bcr-2021-247932.

    PMID: 35260404
  13. 13

    Linear Circumscribed Scleroderma-Like Folliculitis Decalvans: Yet Another Face of a Protean Condition.

    Rezende HD, Dias MFRG, Kempf W, Treüb RM

    International journal of trichology 2018; (10(4)):175-179 doi:10.4103/ijt.ijt_9_18.

    PMID: 30386078

This page is for informational purposes only and does not constitute medical advice. A dermatologist should evaluate your diagnosis, treatment plan, and any new or unusual scalp changes.

Get notified when new evidence is published on Quinquaud folliculitis decalvans.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.